LINGO-1 receptor promotes neuronal apoptosis by inhibiting WNK3 kinase activity

Journal of Biological Chemistry

Volumn 288, Issue 17, 2013, Pages 12152-12160

  Zhang, Zhaohuan ^a   Xu, Xiaohui ^a   Xiang, Zhenghua ^a   Yu, Zhongwang ^a   Feng, Jifeng ^a   He, Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURED CORTICAL NEURONS; EXPRESSION LEVELS; FUNCTIONAL COMPONENTS; INTRACELLULAR DOMAIN; NEURONAL APOPTOSIS; SERUM DEPRIVATION; SIGNALING COMPLEX; SIGNALING PATHWAYS;

ACTIVATION ANALYSIS; AMINO ACIDS; BODY FLUIDS; CELL DEATH; ENZYMES;

NEURONS;

LINGO 1 RECEPTOR; MEMBRANE RECEPTOR; NOGO 66 RECEPTOR; PROTEIN KINASE WNK3; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN TISSUE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; CELL LINE; CEREBRAL CORTEX; HUMANS; MEMBRANE PROTEINS; MYELIN PROTEINS; NERVE TISSUE PROTEINS; NEURONS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84876913440     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.447771     Document Type: Article

References (42)

1. Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., Perrin, S., Sands, B., Crowell, T., Cate, R. L., McCoy, J. M., and Pepinsky, R. B. (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci. 7, 221-228
2. Park, J. B., Yiu, G., Kaneko, S., Wang, J., Chang, J., He, X. L., Garcia, K. C., and He, Z. (2005) A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45, 345-351
3. Mosyak, L., Wood, A., Dwyer, B., Buddha, M., Johnson, M., Aulabaugh, A., Zhong, X., Presman, E., Benard, S., Kelleher, K., Wilhelm, J., Stahl, M. L., Kriz, R., Gao, Y., Cao, Z., Ling, H. P., Pangalos, M. N, Walsh, F. S., and Somers, W. S. (2006) The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition. J. Biol. Chem. 281, 36378-36390
4. Llorens, F., Gil, V., Iraola, S., Carim-Todd, L., Martí, E., Estivill, X., Soriano, E., del Rio, J. A., and Sumoy, L. (2008) Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev. Neurobiol. 68, 521-541
5. Zhang, Z., Xu, X., Zhang, Y., Zhou, J., Yu, Z., and He, C. (2009) LINGO-1 interacts with WNK1 to regulate Nogo-induced inhibition of neurite extension. J. Biol. Chem. 284, 15717-15728
6. Mi, S., Miller, R. H, Lee, X., Scott, M. L., Shulag-Morskaya, S., Shao, Z., Chang, J., Thill, G., Levesque, M., Zhang, M., Hession, C., Sah, D., Trapp, B., He, Z., Jung, V., McCoy, J. M., and Pepinsky, R. B. (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8, 745-751
7. Mi, S., Hu, B., Hahm, K., Luo, Y., Kam Hui, E. S., Yuan, Q., Wong, W. M., Wang, L., Su, H., Chu, T. H., Guo, J., Zhang, W., So, K. F., Pepinsky, B., Shao, Z., Graff, C., Garber, E., Jung, V., Wu, E. X., and Wu, W. (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 13, 1228-1233
8. Satoh, J., Tabunoki, H., Yamamura, T., Arima, K., and Konno, H. (2007) TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 33, 99-107
9. Pepinsky, R. B., Walus, L., Shao, Z., Ji, B., Gu, S., Sun, Y., Wen, D., Lee, X., Wang, Q., Garber, E., and Mi, S. (2011) Production of a PEGylated Fab' of the anti-LINGO-1 Li33 antibody and assessment of its biochemical and functional properties in vitro and in a rat model of remyelination. Biocon-jug. Chem. 22, 200-210
10. Ji, B., Li, M., Wu, W. T., Yick, L. W., Lee, X., Shao, Z., Wang, J., So, K. F., McCoy, J. M., Pepinsky, R. B., Mi, S., and Relton, J. K. (2006) LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 33, 311-320
11. Fu, Q. L., Hu, B., Wu, W., Pepinsky, R. B., Mi, S., and So, K. F. (2008) Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest. Ophthalmol. Vis. Sci. 49, 975-985
12. Inoue, H., Lin, L., Lee, X., Shao, Z., Mendes, S., Snodgrass-Belt, P., Sweigard, H., Engber, T., Pepinsky, B., Yang, L., Beal, M. F., Mi, S., and Isacson, O. (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl. Acad. Sci. U. S. A. 104, 14430-14435
13. Zhao, X. H., Jin, W. L., Wu, J., Mi, S., and Ju, G. (2008) Inactivation of glycogen synthase kinase-3β and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons. Cell. Mol. Neurobiol. 28, 727-735
14. Lööv, C., Fernqvist, M., Walmsley, A., Marklund, N., and Erlandsson, A. (2012) Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons. PLoS ONE 7, e29771
15. Veríssimo, F., and Jordan, P. (2001) WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20, 5562-5569
16. - in and out of cells: implications for control of cell volume and neuronal excitability. Proc. Natl. Acad. Sci. U. S. A. 102, 16783-16788
17. Veríssimo, F., Silva, E., Morris, J. D., Pepperkok, R., and Jordan, P. (2006) Protein kinase WNK3 increases cell survival in a caspase-3-dependent pathway. Oncogene 25, 4172-4182
18. Grand Pré, T., Li, S., and Strittmatter, S. M. (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417, 547-551
19. Saito, T., and Nakatsuji, N. (2001) Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev. Biol. 240, 237-246
20. Liu, X., Wang, Y., Zhang, Y., Zhu, W., Xu, X., Niinobe, M., Yoshikawa, K., Lu, C., and He, C. (2009) Nogo-A inhibits necdin-accelerated neurite outgrowth by retaining necdin in the cytoplasm. Mol. Cell. Neurosci. 41, 51-61
21. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Green-berg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362
22. Qi, B., Qi, Y., Watari, A., Yoshioka, N., Inoue, H., Minemoto, Y., Ya-mashita, K., Sasagawa, T., and Yutsudo, M. (2003) Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. J. Cell. Physiol. 196, 312-318
23. - cotransporters required for normal blood pressure homeostasis. Proc. Natl. Acad. Sci. U. S. A. 102, 16777-16782
24. Xu, B., English, J. M., Wilsbacher, J. L., Stippec, S., Goldsmith, E. J., and Cobb, M. H. (2000) WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275, 16795-16801
25. Xu, B. E., Min, X., Stippec, S., Lee, B. H, Goldsmith, E. J., and Cobb, M. H. (2002) Regulation of WNK1 by an autoinhibitory domain and autophos-phorylation. J. Biol. Chem. 277, 48456-48462
26. de Los Heros, P., Kahle, K. T., Rinehart, J., Bobadilla, N. A., Vázquez, N., San Cristobal, P., Mount, D. B., Lifton, R. P., Hebert, S. C, and Gamba, G. (2006) WNK3 bypasses the tonicity requirement for K-Cl cotransporter activation via a phosphatase-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 103, 1976-1981
27. Holden, S., Cox, J., and Raymond, F. L. (2004) Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). Gene 335, 109-119
28. Lorenzo-Betancor, O., Samaranch, L., García-Martín, E., Cervantes, S., Agúndez, J. A., Jiménez-Jiménez, F. J., Alonso-Navarro, H., Luengo, A., Coria, F., Lorenzo, E., Irigoyen, J., Pastor, P., and Iberian Parkinson's Disease Genetics Study Group Researchers (2011) LINGO1 gene analysis in Parkinson's disease phenotypes. Mov. Disord. 26, 722-727
29. Gerin, C. G., Madueke, I. C, Perkins, T., Hill, S., Smith, K., Haley, B., Allen, S. A., Garcia, R. P., Paunesku, T., and Woloschak, G. (2011) Combination strategies for repair, plasticity, and regeneration using regulation of gene expression during the chronic phase after spinal cord injury. Synapse 65, 1255-1281
30. Fu, Q. L., Hu, B., Li, X., Shao, Z., Shi, J. B., Wu, W., So, K. F., and Mi, S. (2010) LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension. Eur. J. Neurosci. 31, 1091-1097
31. Qiao, Y., Liu, X., Harvard, C., Hildebrand, M. J., Rajcan-Separovic, E., Holden, J. J., and Lewis, M. E. (2008) Autism-associated familial microde-letion of Xp11.22. Clin. Genet. 74, 134-144
32. Zhang, W., Na, T., and Peng, J. B. (2008) WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway. Am. J. Physiol. Renal Physiol. 295, F1472-F1484
33. + channel ROMK1 (Kir1.1). J. Physiol. 571, 275-286
34. - channel regulated by the WNK kinases. J. Physiol. 584, 333-345
35. Jiang, Z. Y., Zhou, Q. L., Holik, J., Patel, S., Leszyk, J., Coleman, K., Choui-nard, M., and Czech, M. P. (2005) Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mito-genesis in 3T3-L1 cells. J. Biol. Chem. 280, 21622-21628
36. Cheng, C. J., and Huang, C. L. (2011) Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. J. Am. Soc. Nephrol. 22, 460-471
37. Garzon-Muvdi, T., Schiapparelli, P., ap Rhys, C., Guerrero-Cazares, H., Smith, C., Kim, D. H, Kone, L., Farber, H., Lee, D. Y., An, S. S., Levchenko, A., and Quinones-Hinojosa, A. (2012) Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS Biol. 10, e1001320
38. Brunet, A., Datta, S. R., and Greenberg, M. E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297-305
39. Arboleda, G., Morales, L. C, Benítez, B., and Arboleda, H. (2009) Regulation of ceramide-induced neuronal death: cell metabolism meets neuro-degeneration. Brain Res. Rev. 59, 333-346
40. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
41. Stambolic, V., and Woodgett, J. R. (1994) Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem. J. 303, 701-704
42. Ambacher, K. K., Pitzul, K. B., Karajgikar, M., Hamilton, A., Ferguson, S. S., and Cregan, S. P. (2012) The JNK-and AKT/GSK3β-signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS ONE 7, e46885